Skip to main content
Erschienen in:

16.12.2021 | Original

Feasibility of conservative fluid administration and deresuscitation compared with usual care in critical illness: the Role of Active Deresuscitation After Resuscitation-2 (RADAR-2) randomised clinical trial

verfasst von: Jonathan A. Silversides, Ross McMullan, Lydia M. Emerson, Ian Bradbury, Jonathan Bannard-Smith, Tamas Szakmany, John Trinder, Anthony J. Rostron, Paul Johnston, Andrew J. Ferguson, Andrew J. Boyle, Bronagh Blackwood, John C. Marshall, Daniel F. McAuley

Erschienen in: Intensive Care Medicine | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Fluid overload is common in critical illness and is associated with mortality. This study investigated the feasibility of a randomised trial comparing conservative fluid administration and deresuscitation (active removal of accumulated fluid using diuretics or ultrafiltration) with usual care in critical illness.

Methods

Open-label, parallel-group, allocation-concealed randomised clinical feasibility trial. Mechanically ventilated adult patients expected to require critical care beyond the next calendar day were enrolled between 24 and 48 h following admission to the intensive care unit (ICU). Patients were randomised to either a 2-stage fluid strategy comprising conservative fluid administration and, if fluid overload was present, active deresuscitation, or usual care. The primary endpoint was fluid balance in the 24 h up to the start of study day 3. Secondary endpoints included cumulative fluid balance, mortality, and duration of mechanical ventilation.

Results

One hundred and eighty patients were randomised. After withdrawal of 1 patient, 89 patients assigned to the intervention were compared with 90 patients assigned to the usual care group. The mean plus standard deviation (SD) 24-h fluid balance up to study day 3 was lower in the intervention group (− 840 ± 1746 mL) than the usual care group (+ 130 ± 1401 mL; P < 0.01). Cumulative fluid balance was lower in the intervention group at days 3 and 5. Overall, clinical outcomes did not differ significantly between the two groups, although the point estimate for 30-day mortality favoured the usual care group [intervention arm: 19 of 90 (21.6%) versus usual care: 14 of 89 (15.6%), P = 0.32]. Baseline imbalances between groups and lack of statistical power limit interpretation of clinical outcomes.

Conclusions

A strategy of conservative fluid administration and active deresuscitation is feasible, reduces fluid balance compared with usual care, and may cause benefit or harm. In view of wide variations in contemporary clinical practice, large, adequately powered trials investigating the clinical effectiveness of conservative fluid strategies in critically ill patients are warranted.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Moraes RB, Friedman G, Viana MV et al (2013) Aldosterone secretion in patients with septic shock: a prospective study. Arq Bras Endocrinol Metabol 57:636–641CrossRefPubMed Moraes RB, Friedman G, Viana MV et al (2013) Aldosterone secretion in patients with septic shock: a prospective study. Arq Bras Endocrinol Metabol 57:636–641CrossRefPubMed
5.
Zurück zum Zitat Wagener G, Bakker J (2015) Vasopressin in cirrhosis and sepsis: physiology and clinical implications. Minerva Anestesiol 81:1377–1383PubMed Wagener G, Bakker J (2015) Vasopressin in cirrhosis and sepsis: physiology and clinical implications. Minerva Anestesiol 81:1377–1383PubMed
15.
Zurück zum Zitat Silversides JA, Major E, Ferguson AJ et al (2017) Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: a systematic review and meta-analysis. Intensive Care Med 43:155–170. https://doi.org/10.1007/s00134-016-4573-3CrossRefPubMed Silversides JA, Major E, Ferguson AJ et al (2017) Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: a systematic review and meta-analysis. Intensive Care Med 43:155–170. https://​doi.​org/​10.​1007/​s00134-016-4573-3CrossRefPubMed
16.
Zurück zum Zitat National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Wiedemann HP, Wheeler AP et al (2006) Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 354:2564–2575. https://doi.org/10.1056/NEJMoa062200CrossRef National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Wiedemann HP, Wheeler AP et al (2006) Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 354:2564–2575. https://​doi.​org/​10.​1056/​NEJMoa062200CrossRef
18.
Zurück zum Zitat Silversides J, Marshall JC, Ferguson A et al (2018) Role of Active Deresuscitation After Resuscitation-2 (RADAR-2)—a pilot randomised controlled trial of conservative fluid administration and deresuscitation in critical illness: study protocol. Crit Care Horizons 1–7 Silversides J, Marshall JC, Ferguson A et al (2018) Role of Active Deresuscitation After Resuscitation-2 (RADAR-2)—a pilot randomised controlled trial of conservative fluid administration and deresuscitation in critical illness: study protocol. Crit Care Horizons 1–7
23.
Zurück zum Zitat Weiss, (2004) The impact of event scale – revised. In: Wilson JP, Keane TM (eds) Assessing psychological trauma and PTSD. The Guilford Press, New York, pp 168–189 Weiss, (2004) The impact of event scale – revised. In: Wilson JP, Keane TM (eds) Assessing psychological trauma and PTSD. The Guilford Press, New York, pp 168–189
29.
Zurück zum Zitat Bellomo R, Prowle JR, Echeverri JE (2010) Diuretic therapy in fluid-overloaded and heart failure patients. In: Ronco C, Costanzo MR, Bellomo R, Maisel AS (eds) Fluid overload. KARGER, Basel, pp 153–163CrossRef Bellomo R, Prowle JR, Echeverri JE (2010) Diuretic therapy in fluid-overloaded and heart failure patients. In: Ronco C, Costanzo MR, Bellomo R, Maisel AS (eds) Fluid overload. KARGER, Basel, pp 153–163CrossRef
Metadaten
Titel
Feasibility of conservative fluid administration and deresuscitation compared with usual care in critical illness: the Role of Active Deresuscitation After Resuscitation-2 (RADAR-2) randomised clinical trial
verfasst von
Jonathan A. Silversides
Ross McMullan
Lydia M. Emerson
Ian Bradbury
Jonathan Bannard-Smith
Tamas Szakmany
John Trinder
Anthony J. Rostron
Paul Johnston
Andrew J. Ferguson
Andrew J. Boyle
Bronagh Blackwood
John C. Marshall
Daniel F. McAuley
Publikationsdatum
16.12.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
Intensive Care Medicine / Ausgabe 2/2022
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-021-06596-8

Neu im Fachgebiet AINS

Frauen mit Apoplex in Deutschland nicht benachteiligt – oder doch?

Eine Analyse von Daten des statistischen Bundesamtes spricht dafür, dass Frauen in der Schlaganfallbehandlung nicht benachteiligt sind. Im Detail bleiben aber Fragen offen.

Perkutane Ablation – ungenutztes Potenzial für die Schmerztherapie?

Geht es nach US-Versicherungsdaten, ist die perkutane Ablation eine vorteilhafte, aber zu selten genutzte Option in der Schmerzlinderung von Personen mit bestimmten Tumoren. Wichtige Fragen bleiben allerdings unbeantwortet.

So oft sind chronische Schmerzen mit Depression und Angststörung verbunden

Eine aktuelle Studie aus den USA und Australien legt nahe, dass rund 40% der Patientinnen und Patienten mit chronischen Schmerzen unter Depressionen und Angstzuständen leidet. Allerdings variiert die Prävalenz je nach Schmerzerkrankung.

Ärztinnen überholen Ärzte bei Praxisgründungen

Bei Praxisgründungen haben inzwischen die Frauen deutlich die Nase vorn: Seit zehn Jahren wagen laut apoBank mehr Ärztinnen als Ärzte den Schritt in die Selbstständigkeit. In puncto Finanzierung sind sie aber vorsichtiger als die männlichen Kollegen.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.